ArticleJournal of neurology, neurosurgery, and psychiatry2000
Brain tumours in Sweden 1996: care and costs.
Article in Journal of neurology, neurosurgery, and psychiatry, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Long-term neurocognitive and other side effects of radiotherapy, with or without chemotherapy, for glioma.The Cochrane database of systematic reviews · 2019Pooled it
- Economics of Malignant Gliomas: A Critical Review.Journal of oncology practice · 2015Pooled it
- Cost-effectiveness of proton beam therapy vs. conventional radiotherapy for patients with brain tumors in Sweden: results from a non-randomized prospective multicenter study.Cost effectiveness and resource allocation : C/E · 2024Article
- Global Landscape of Glioblastoma Multiforme Management in the Stupp Protocol Era: Systematic Review Protocol.International journal of surgery protocols · 2021Article
- The economic burden of prostate cancer - a Swedish prevalence-based register study.BMC health services research · 2020Article
- Determining the unmet needs of patients with intracranial meningioma-a qualitative assessment.Neuro-oncology practice · 2020Article
- Epilepsy: A Call for Help.Brain sciences · 2018Article
- In vitro antineoplastic effects of brivaracetam and lacosamide on human glioma cells.Journal of experimental & clinical cancer research : CR · 2017Article
- The economic burden of human papillomavirus-related precancers and cancers in Sweden.PloS one · 2017Article
- A review of the economic burden of glioblastoma and the cost effectiveness of pharmacologic treatments.PharmacoEconomics · 2014Review
- The size, burden and cost of disorders of the brain in the UK.Journal of psychopharmacology (Oxford, England) · 2013Article
- Utilization and cost of health care services associated with primary malignant brain tumors in the United States.Journal of neuro-oncology · 2007Article
- Cost-of-illness studies : a review of current methods.PharmacoEconomics · 2006Review
- Quality of life, out-of-pocket expenditures, and indirect costs among patients with the central nervous system tumors in Thailand.Journal of neurosciences in rural practiceArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesBrain tumours cause considerable concern due to a high mortality and there are increasing efforts to provide adequate care, sometimes outside hospitals. Health care utilisation, direct costs of care, and the indirect social cost of morbidity and early mortality caused by brain tumours in Sweden in the year 1996 was analysed.
methodsQuantification of ambulatory care, care in hospital, long term and palliative/terminal care, drug consumption, temporary as well as long term morbidity, and mortality from comprehensive national data sources. Direct costs were calculated using 1996 charges. Indirect costs were calculated by sex and age specific salaries. A sensitivity analysis considered the impact of alternative estimates of each item.
resultsIndirect costs were 75% of the total and were caused mainly by early mortality. Direct costs were predominantly for care in hospital, long term care, and home health care. Among direct costs, astrocytomas III-IV and meningiomas accounted for 42% and 30% respectively.
conclusionsThe cost of illness from brain tumours reflects the characteristics of these malignancies. Despite their low incidence rate, the economic impact caused by high mortality among young persons is a predominant trait. Costs of acute hospital care and also long term care and home care are considerable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.